Update: 22.04.2025
Last week: 15 week 2025 (07.04.2025 - 13.04.2025)
Last full month: March 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 128 | -2.5% | 12.7% | 0 | 22 733 709 | -2.2% | 9.5% | 0.1 | -2.8% |
| MoM | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| YTD | 137 637 | 28.6% | 12.8% | 1.9 | 295 977 157 | 23.2% | 9.4% | 0.1 | 9.6% |
| MAT | 452 038 | 25.4% | 12.9% | 3.1 | 894 888 941 | 20.9% | 9.3% | 1.1 | -5.1% |
| BRAINMAX | |||||||||
| WoW | 2 833 | -0.4% | 100.0% | 0 | 9 746 417 | -2.0% | 100.0% | 0 | -0.4% |
| MoM | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| YTD | 36 880 | 136.1% | 100.0% | 0 | 127 166 085 | 128.1% | 100.0% | 0 | 136.1% |
| MAT | 103 923 | 98.1% | 100.0% | 0 | 358 145 581 | 95.0% | 100.0% | 0 | 98.1% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 926 | -1.9% | 44.8% | -1.6 | 53 855 666 | -4.0% | 36.7% | -1.3 | 1.7% |
| MoM | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| YTD | 243 750 | -3.2% | 45.9% | 1.7 | 789 443 098 | -1.8% | 37.6% | 1.5 | -6.7% |
| MAT | 820 982 | -5.8% | 46.0% | 0.4 | 2 588 030 787 | -5.6% | 37.6% | -1.3 | -6.7% |
| MIGRENIUM | |||||||||
| WoW | 7 939 | -4.6% | 0.3% | 0 | 2 816 764 | -4.2% | 0.5% | 0 | 1.1% |
| MoM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| YTD | 124 496 | -32.7% | 0.4% | -0.2 | 43 544 843 | -18.4% | 0.5% | -0.2 | 3.9% |
| MAT | 507 427 | -21.0% | 0.4% | -0.1 | 171 812 380 | 20.2% | 0.6% | 0.1 | 0.1% |
| MODELAX-N | |||||||||
| WoW | 26 606 | -4.5% | 18.6% | -1.1 | 14 168 721 | -4.1% | 13.7% | -0.8 | 1.1% |
| MoM | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| YTD | 453 907 | -5.4% | 20.7% | -3.1 | 235 816 120 | 19.7% | 14.7% | -0.1 | 8.7% |
| MAT | 1 437 822 | 6.8% | 20.8% | 0.4 | 698 085 551 | 44.1% | 14.2% | 2.3 | 4.9% |
| REDUXIN | |||||||||
| WoW | 11 953 | 3.5% | 31.7% | 0.5 | 64 138 958 | 0.1% | 43.7% | 0.3 | 1.7% |
| MoM | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| YTD | 169 209 | -10.5% | 31.8% | -1.3 | 922 252 976 | -10.6% | 43.9% | -2.4 | -6.7% |
| MAT | 575 619 | -7.2% | 32.2% | -0.2 | 3 054 041 955 | -0.3% | 44.4% | 0.9 | -6.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 744 | 4.5% | 9.9% | 0.3 | 17 109 536 | 4.0% | 11.7% | 0.5 | 1.7% |
| MoM | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| YTD | 52 300 | 5.7% | 9.8% | 1.2 | 236 259 866 | 9.1% | 11.2% | 1.5 | -6.7% |
| MAT | 170 173 | 1.0% | 9.5% | 0.7 | 741 381 909 | 6.6% | 10.8% | 0.9 | -6.7% |
| SALVISAR | |||||||||
| WoW | 13 983 | 5.8% | 1.9% | 0 | 7 062 399 | 5.7% | 1.8% | 0 | 4.0% |
| MoM | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
| YTD | 204 324 | 38.7% | 1.9% | 0.6 | 99 229 223 | 76.6% | 1.8% | 0.7 | -4.7% |
| MAT | 628 770 | 30.4% | 1.6% | 0.5 | 283 984 276 | 69.8% | 1.5% | 0.5 | -6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 137 637 | 28.6% | 12.8% | 1.9 | 295 977 157 | 23.2% | 9.4% | 0.1 | 9.6% |
| BRAINMAX | 36 880 | 136.1% | 100.0% | 0 | 127 166 085 | 128.1% | 100.0% | 0 | 136.1% |
| GOLDLINE PLUS | 243 750 | -3.2% | 45.9% | 1.7 | 789 443 098 | -1.8% | 37.6% | 1.5 | -6.7% |
| MIGRENIUM | 124 496 | -32.7% | 0.4% | -0.2 | 43 544 843 | -18.4% | 0.5% | -0.2 | 3.9% |
| MODELAX-N | 453 907 | -5.4% | 20.7% | -3.1 | 235 816 120 | 19.7% | 14.7% | -0.1 | 8.7% |
| REDUXIN CAPS | 169 209 | -10.5% | 31.8% | -1.3 | 922 252 976 | -10.6% | 43.9% | -2.4 | -6.7% |
| REDUXIN FORTE | 52 300 | 5.7% | 9.8% | 1.2 | 236 259 866 | 9.1% | 11.2% | 1.5 | -6.7% |
| SALVISAR | 204 324 | 38.7% | 1.9% | 0.6 | 99 229 223 | 76.6% | 1.8% | 0.7 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 452 038 | 25.4% | 12.9% | 3.1 | 894 888 941 | 20.9% | 9.3% | 1.1 | -5.1% |
| BRAINMAX | 103 923 | 98.1% | 100.0% | 0 | 358 145 581 | 95.0% | 100.0% | 0 | 98.1% |
| GOLDLINE PLUS | 820 982 | -5.8% | 46.0% | 0.4 | 2 588 030 787 | -5.6% | 37.6% | -1.3 | -6.7% |
| MIGRENIUM | 507 427 | -21.0% | 0.4% | -0.1 | 171 812 380 | 20.2% | 0.6% | 0.1 | 0.1% |
| MODELAX-N | 1 437 822 | 6.8% | 20.8% | 0.4 | 698 085 551 | 44.1% | 14.2% | 2.3 | 4.9% |
| REDUXIN CAPS | 575 619 | -7.2% | 32.2% | -0.2 | 3 054 041 955 | -0.3% | 44.4% | 0.9 | -6.7% |
| REDUXIN FORTE | 170 173 | 1.0% | 9.5% | 0.7 | 741 381 909 | 6.6% | 10.8% | 0.9 | -6.7% |
| SALVISAR | 628 770 | 30.4% | 1.6% | 0.5 | 283 984 276 | 69.8% | 1.5% | 0.5 | -6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 128 | -2.5% | 12.7% | 0 | 22 733 709 | -2.2% | 9.5% | 0.1 | -2.8% |
| BRAINMAX | 2 833 | -0.4% | 100.0% | 0 | 9 746 417 | -2.0% | 100.0% | 0 | -0.4% |
| GOLDLINE PLUS | 16 926 | -1.9% | 44.8% | -1.6 | 53 855 666 | -4.0% | 36.7% | -1.3 | 1.7% |
| MIGRENIUM | 7 939 | -4.6% | 0.3% | 0 | 2 816 764 | -4.2% | 0.5% | 0 | 1.1% |
| MODELAX-N | 26 606 | -4.5% | 18.6% | -1.1 | 14 168 721 | -4.1% | 13.7% | -0.8 | 1.1% |
| REDUXIN CAPS | 11 953 | 3.5% | 31.7% | 0.5 | 64 138 958 | 0.1% | 43.7% | 0.3 | 1.7% |
| REDUXIN FORTE | 3 744 | 4.5% | 9.9% | 0.3 | 17 109 536 | 4.0% | 11.7% | 0.5 | 1.7% |
| SALVISAR | 13 983 | 5.8% | 1.9% | 0 | 7 062 399 | 5.7% | 1.8% | 0 | 4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| BRAINMAX | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| GOLDLINE PLUS | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| MIGRENIUM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| MODELAX-N | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| REDUXIN CAPS | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| REDUXIN FORTE | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| SALVISAR | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs